SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): AUGUST 27, 2002
-----------------------------------------------------------------
IMMUNOGEN, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
MASSACHUSETTS 0-17999 04-2726691
--------------- ------------ -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
128 SIDNEY STREET, CAMBRIDGE, MA 02139
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (617) 995-2500
ITEM 5. OTHER EVENTS.
On August 27, 2002, ImmunoGen, Inc. (the "Company") announced that, effective
immediately, its Board of Directors has authorized the repurchase of up to 4.1
million shares of the Company's common stock. The repurchases are to be made at
the discretion of management and as market conditions warrant. No time limit was
set for the completion of the repurchase program.
The press release announcing the common stock repurchase program is filed as an
exhibit to this Form 8-K, and is incorporated by reference into this Item 5. The
foregoing description of the press release and the transactions contemplated
therein is qualified in its entirety by reference to such exhibit.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
99.1 The Company's Press Release dated August 27, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
IMMUNOGEN, INC.
----------------
(Registrant)
Date: August 27, 2002 /s/ Gregg D. Beloff
-------------------
Gregg D. Beloff
Chief Financial Officer and Vice President
EXHIBIT INDEX
--------------
EXHIBIT
NUMBER DESCRIPTION
-------- -----------
99.1 The Company's Press Release dated August 27, 2002.